GRS Advisors’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-86,052
Closed -$1.27M 36
2024
Q1
$1.27M Hold
86,052
0.17% 28
2023
Q4
$1.23M Sell
86,052
-1,347,586
-94% -$19.1M 0.2% 27
2023
Q3
$20M Buy
+1,433,638
New +$18.3M 3.54% 14
2023
Q1
Sell
-1,551,363
Closed -$19.3M 39
2022
Q4
$19.3M Buy
+1,551,363
New +$19.8M 4.61% 9
2019
Q2
Sell
-174,000
Closed -$3.39M 30
2019
Q1
$3.39M Buy
+174,000
New +$3.3M 1.99% 20

Other funds holding SBRA

GRS Advisors's SBRA Position: Q2 2024 in Review

GRS Advisors sold out of Sabra Healthcare REIT (SBRA) in Q2 2024, closing a stake of 86,052 shares — an estimated $1.27M sold.

GRS Advisors first reported a position in SBRA in Q1 2019 and held it in 5 quarters. The position peaked at $20M in Q3 2023. 355 funds tracked by Wall St. Rank hold SBRA as of Q2 2024.

  • GRS Advisors reported no remaining Sabra Healthcare REIT position as of Q2 2024 after selling out during the quarter.
  • GRS Advisors sold 86,052 Sabra Healthcare REIT shares in Q2 2024, an estimated $1.27M.
  • GRS Advisors first reported a position in Sabra Healthcare REIT in Q1 2019 and held it in 5 quarters.
  • GRS Advisors's Sabra Healthcare REIT position peaked at $20M in Q3 2023.
  • 355 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2024.

Based on GRS Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.